RadNet Inc (RDNT) FinancialsRDNTRadNet Inc

RadNet, Inc. (RDNT) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Imaging Centers, accounting for 96.6% of total sales, equivalent to $601.82M. Other significant revenue streams include Digital health and Elimination of intersegment revenues. Understanding this composition is critical for investors evaluating how RDNT navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, RadNet, Inc. maintains a gross margin of 22.40%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 2.70%, while the net margin is -0.37%. These profitability ratios, combined with a Return on Equity (ROE) of -2.08%, provide a clear picture of how effectively RDNT converts its operational activities into shareholder value.

In the context of the broader market, RDNT competes directly with industry leaders such as CON and OPCH. With a market capitalization of $5.41B, it holds a leading position in the sector. When comparing efficiency, RDNT's gross margin of 22.40% stands against CON's 28.41% and OPCH's 17.79%. Such benchmarking helps identify whether RadNet, Inc. is trading at a premium or discount relative to its financial performance.

RadNet's total revenue has shown consistent growth, with Q2 2026 revenue at $622.7 million, a 25% increase from the previous year. However, net income has been inconsistent, with a reported $7.5 million in Q2 2026, down from $14.5 million a year earlier, indicating some financial strain.